title: Effect of chlorhexidine bathing and other infection control practices on the Benefits of Universal Glove and Gown (BUGG) trial: a subgroup analysis.
abstract: We report the results of a subgroup analysis of the Benefits of Universal Glove and Gown trial. In 20 intensive care units, the reduction in acquisition of methicillin-resistant Staphylococcus aureus observed in this trial was observed in units also using chlorhexidine bathing and in those that previously performed active surveillance.
authors.affiliation: 1University of Maryland School of Medicine,Baltimore,Maryland.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Morgan
authors.affiliation: 1University of Maryland School of Medicine,Baltimore,Maryland.
authors.forename: Lisa
authors.initials: L
authors.lastname: Pineles
authors.affiliation: 1University of Maryland School of Medicine,Baltimore,Maryland.
authors.forename: Michelle
authors.initials: M
authors.lastname: Shardell
authors.affiliation: 3Section of Infectious Diseases,Boston University School of Medicine,Boston,Massachusetts.
authors.forename: Carol
authors.initials: C
authors.lastname: Sulis
authors.affiliation: 4Department of Medicine,University of Miami Miller School of Medicine,Miami,Florida.
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Kett
authors.affiliation: 5Division of Infectious Diseases,Department of Medicine,University Health System,University of Texas Health Science Center at San Antonio,San Antonio,Texas.
authors.forename: Jason
authors.initials: J
authors.lastname: Bowling
authors.affiliation: 6Yale New Haven Health System-Center for Healthcare Solutions,New Haven,Connecticut. Members of the study group are listed at the end of the text.
authors.forename: Beverly M
authors.initials: BM
authors.lastname: Belton
authors.affiliation: 1University of Maryland School of Medicine,Baltimore,Maryland.
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Harris
mesh_terms: D001494:Baths / Q000379:methods*; D002710:Chlorhexidine / Q000627:therapeutic use*; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control; D004202:Disinfectants / Q000627:therapeutic use; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D017053:Infection Control / Q000379:methods / Q000706:statistics & numerical data; D007362:Intensive Care Units / Q000706:statistics & numerical data; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D017063:Outcome Assessment, Health Care; D011481:Protective Clothing; D065507:Vancomycin-Resistant Enterococci / Q000187:drug effects / Q000302:isolation & purification
chemical_list: D004202:Disinfectants; D002710:Chlorhexidine